SHR-A1811 Combined With Bevacizumab in HER2-positive Breast Cancer With Brain Metastases
Clinical trial NCT06361979 · UNKNOWN
Trial details
- NCT number
- NCT06361979
- Sponsor
- Huihua Xiong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2025-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.